Cargando…

The ability of the neonatal immune response to handle SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales:	Götzinger, Florian, Santiago-Garcia, Begoña, Fumadó-Pérez, Victòria, Brinkmann, Folke, Tebruegge, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826031/ https://www.ncbi.nlm.nih.gov/pubmed/33484660 http://dx.doi.org/10.1016/S2352-4642(21)00002-X

Ejemplares similares

The ability of the neonatal immune response to handle SARS-CoV-2 infection – Authors' reply
por: Gale, Chris, et al.
Publicado: (2021)

Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: a multicentre Paediatric Tuberculosis Network European Trials Group (ptbnet) study
por: Basu Roy, Robindra, et al.
Publicado: (2020)

Managing neonates with respiratory failure due to SARS-CoV-2
por: De Luca, Daniele
Publicado: (2020)

Tuberkulose – Update 2022
por: Kainz, Katharina, et al.
Publicado: (2023)

Favorable outcomes among neonates not separated from their symptomatic SARS-CoV-2-infected mothers
por: Martenot, Antoine, et al.
Publicado: (2020)

Neonatal Multisystem Inflammatory Syndrome (MIS-N) Associated with Maternal SARS-CoV-2 Exposure
por: Gupta, Priyanka, et al.
Publicado: (2022)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients
por: Scherer, Erin M., et al.
Publicado: (2022)

Handling the COVID-19 pandemic in the oncological setting
por: Mussetti, Alberto, et al.
Publicado: (2020)

Juvenile Dermatomyositis Triggered by SARS-CoV-2
por: Liquidano-Perez, Eduardo, et al.
Publicado: (2021)

Protective humoral immunity in SARS-CoV-2 infected pediatric patients
por: Zhang, Yaguang, et al.
Publicado: (2020)

Tracking immune correlates of protection for emerging SARS-CoV-2 variants
por: Nilles, Eric J, et al.
Publicado: (2023)

Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

An action plan for pan-European defence against new SARS-CoV-2 variants
por: Priesemann, Viola, et al.
Publicado: (2021)

Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant
por: Chemaitelly, Hiam, et al.
Publicado: (2021)

Cross-reactive antibody immunity against SARS-CoV-2 in children and adults
por: Fraley, Elizabeth, et al.
Publicado: (2021)

Increased immune escape of the new SARS-CoV-2 variant of concern Omicron
por: Hu, Jie, et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence in Spain – Authors' reply
por: Pollán, Marina, et al.
Publicado: (2020)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
por: Jangra, Sonia, et al.
Publicado: (2021)

Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage
por: Gruell, Henning, et al.
Publicado: (2022)

Significantly reduced abilities to cross-neutralize SARS-CoV-2 variants by sera from convalescent COVID-19 patients infected by Delta or early strains
por: Pan, Ting, et al.
Publicado: (2021)

Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections
por: Priesemann, Viola, et al.
Publicado: (2021)

Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2
por: Pfaff, Florian, et al.
Publicado: (2022)

The Ariadne principles: how to handle multimorbidity in primary care consultations
por: Muth, Christiane, et al.
Publicado: (2014)

An outbreak of Mycobacterium marinum infection associated with handling seabass in China
por: Zhao, Qing, et al.
Publicado: (2022)

Measles Immunization: Worth Considering Containment Strategy for SARS-CoV-2 Global Outbreak
por: Hanker, Varnit S.
Publicado: (2020)

Acute myelopathies associated to SARS-CoV-2 infection: Viral or immune-mediated damage?()
por: Canavero, Isabella, et al.
Publicado: (2021)

Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose
por: Bladh, Oscar, et al.
Publicado: (2023)

SARS-CoV-2 rapid antigen detection tests
por: Weitzel, Thomas, et al.
Publicado: (2021)

Evaluating the impact of sample storage, handling, and technical ability on the decay and recovery of SARS-CoV-2 in wastewater
por: Beattie, Rachelle E., et al.
Publicado: (2022)

Where is the next SARS-CoV-2 variant of concern?
por: Dennehy, John J, et al.
Publicado: (2022)

Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months
por: Peng, Pai, et al.
Publicado: (2021)

ORF9c and ORF10 as accessory proteins of SARS-CoV-2 in immune evasion
por: Zandi, Milad
Publicado: (2022)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

Immunoassays for anti-SARS-CoV-2 antibodies: recent insights
por: Van Elslande, Jan, et al.
Publicado: (2021)

Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection
por: Blom, Kim, et al.
Publicado: (2022)

Multiorgan and Renal Tropism of SARS-CoV-2
por: Puelles, Victor G., et al.
Publicado: (2020)

T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals
por: Jordan, Stanley C., et al.
Publicado: (2021)

SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients
por: Deng, Yao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mu0ssr7jm4lnu703sktvq4aqr0